World Bank Announces Plan To Implement Long-Term Development Projects To Fight HIV AIDS In Africa
The World Bank on Wednesday announced a four-year plan to tackle HIV/AIDS in Africa that shifts its mission from providing emergency relief to implementing long-term development projects, Reuters reports (Wroughton, Reuters, 5/14).
VOA News Publishes Several HIV AIDS-Related Articles
VOA News on Tuesday published several articles about HIV/AIDS in Africa. Summaries appear below."African Countries Seek Common Approach Against HIV/AIDS": Leaders of several African countries are proposing a common African approach to fighting the spread of HIV/AIDS after the most recent 2007 statistics show that 24.
About 39 Of IDUs Living In Spain Are HIV-Positive, IHRA Report Says
As many as 39% of the approximately 84, 000 injection drug users living in Spain are HIV-positive, and as many as 73% are living with hepatitis C, according to a recent report by the International Harm Reduction Association, Spain's El Pa~A s reports.
Biopure Announces Publication Of Phase II Proof-of-Concept Coronary Trial
Biopure Corporation (Nasdaq: BPUR) announced that the results from its Phase II coronary revascularization trial have been published in the peer-reviewed EuroIntervention Journal. The paper is entitled "Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization.
Regado Biosciences' REG1 Anticoagulation System Study Results Published In The Journal Of Thrombosis And Haemostasis
Regado Biosciences announced the Journal of Thrombosis and Haemostasis, the official journal of the International Society on Thrombosis and Haemostasis, has published the Phase 1c clinical results of the Company's REG1 anticoagulation system.
Screening For Diabetes Potentially Cost-Effective For UK
A new University of Leicester study reveals that screening people who are at risk of developing diabetes could be a cost-effective health policy and improve the lives of patients.
Progen Resumes Phase 1 Development Of Anti Cancer Agent, PG 11047
Progen Pharmaceuticals Limited (ASX:PGL; Nasdaq: PGLA) announced that the Company has resumed patient enrolment in the phase 1 dose-escalation study of its recently acquired polyamine analogue, PG-11047 (formerly CGC-11047) for patients with advanced cancer.
Estimated 3.2 Million Burmese Potentially Affected By Cyclone
As many as 3.2 million Burmese are estimated to be affected by the devastation caused by Cyclone Nargis, according to geographic risk models developed by researchers from the Johns Hopkins Bloomberg School of Public Health and Lehman College, CUNY..
Antiabortion Democrat Wins Special Election To Fill House Seat In Mississippi
A conservative Democrat who, according to the Washington Post, ran a campaign focused on "support for gun rights and opposition to abortion, " won a special election Tuesday to fill the Republican-held U.S. House seat in northern Mississippi. Prentiss County, Miss.
Insurers Launch Three-Year, 13M Incentive Program For Pennsylvania Physicians
Six insurers in Southeastern Pennsylvania on Tuesday launched a three-year, $13 million initiative to compensate physicians who track their patients' health care and conditions, the Philadelphia Inquirer reports. The incentive program is part of the first phase of Gov.